Cepheid
Gopi Soundararajan is an accomplished executive in the medical technology field, currently serving as Vice President of Global R&D, Product Development, and Operational Excellence at Cepheid since July 2020. With a career spanning over two decades, Gopi has held pivotal roles at BD, Danaher Corporation, Medtronic, and Masimo, overseeing significant program management, product development, and innovation initiatives. Notable achievements include leading cross-functional teams, developing complex medical devices, and pioneering advancements in heart valve technologies. Gopi co-founded ReUsense, a start-up focused on low-cost diagnostics for emerging markets, and has extensive experience in regulatory compliance and strategic business planning. Gopi holds an Executive MBA from the USC Marshall School of Business and advanced degrees in Biomedical Engineering and Computer Science.
This person is not in any offices
Cepheid
10 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.